Sientra (SIEN) Misses Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Sientra Reports Third Quarter 2017 Financial Results
November 7, 2017 4:01 PM ESTCompleted FDA Facility Inspection
Completed Acquisition of Miramar Labs and Making Significant Progress with Integration
SANTA BARBARA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company, today announced its financial results for the third quarter ended September 30, 2017.
Jeffrey M. Nugent, Chairman and Chief Executive Officer of Sientra, said, We continue to advance on each of our strategic initiatives, highlighted by the completion of the FDA inspection of our U.S. manufacturing facility in... More



